|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Risk Factors for Posterior Compared to Anterior Ischemic Stroke: An Observational Study of the Registry of the Canadian Stroke Network显示文摘 | Subramanian G Silva J Silver F L Fang J Kapral M K Oczkowski W Gould L O’donnell M J | 2009 | Neuroepidemiology2009，，1： | 2 |
| 2 | Organisational Identification and Leader Member Exchange Influences on Customer Orientation and Organisational Citizenship Behaviours 显示文摘 | FARRELL M A OCZKOWSKI E | 2012 | Journal of Strategic Marketing2012，20，4： | 1 |
| 3 | Gastrointestinal bleeding after acute ischemic stroke显示文摘 | M J. O?Donnell M K. Kapral J Fang G Saposnik J W. Eikelboom W Oczkowski J Silva L Gould C D?Uva F L. Silver | 2008 | Neurology2008，，9： | 1 |
| 4 | An examination of the form of market orientation in Australian companies显示文摘 | OCZKOWSKI E FARRELL M A | 1998 | Australasian Marketing Journal1998，6，2： | 1 |
| 5 | Risk Factors for Posterior Compared to Anterior Ischemic Stroke: An Observational Study of the Registry of the Canadian Stroke Network显示文摘 | Subramanian G Silva J Silver F L Fang J Kapral M K Oczkowski W Gould L O’donnell M J | 2009 | Neuroepidemiology2009，，1： | 1 |
| 6 | Discriminating between Measurement Scales Using Non-nested Tests and Two-stage Least Squares Estimatiors:The Cose of Market Orientation显示文摘 | Oczkowski E & Farrel M A | 1998 | International Journal of Research in Marketing1998，15，4： | 1 |
| 7 | Organisation and expression of mitochon drial atp9 genes from CMS and fertile carrots显示文摘 | Szklarczyk M Oczkowski M Augustyniak H | 2000 | Theor Appl Genet2000，100，： | 1 |
| 8 | Properties of montmorillonite-eontaining natural rubber 显示文摘 | Jurkowska B Jurkowski B Oczkowski M | 2007 | Journal of Ap plied Polymer Science2007，106，1： | 1 |
| 9 | Service Worker Customer Orientation,Organisation/Job Fit and Perceived Organisational Support显示文摘 | Farrell M A Oczkowski E | 2009 | Journal of Strategic Marketing2009，17，2： | 1 |
| 10 | Properties of montmofillonite-containing natural rubber显示文摘 | Jurkowska B Jurkowski B Oczkowski M | 2007 | Journal of Applied Polymer Science2007，106，1： | 1 |
| 11 | Preadmission antithrombotic treatment and stroke severity in patients with atrial fibrillation and acute ischaemic stroke:an observational study显示文摘 | O′DONNELL M OCZKOWSKI W FANG J | 2006 | Lancet Neurol2006，5，9： | 1 |
| 12 | Preadmission an- tithrombotic treatment and stroke severity in patients with atrial fi- brillation and acute ischaemic stroke : an observational study 显示文摘 | O' Donnell M Oczkowski W Fang J | 2006 | Lancet Neurol2006，5，9： | 1 |
| 13 | Organisation and expression of mitochondrial atp9 genes from CMS and fertile carrots显示文摘 | Szklarczyk M Oczkowski M Augustyniak H | | 0，，02： | 1 |
| 14 | Health-related quality-of-life and health-utility reporting in critical care显示文摘Mortality is a well-established patient-important outcome in critical care studies.In contrast,morbidity is less uniformly reported(given the myriad of critical care illnesses and complications of each)but may have a common end-impact on a patient’s functional capacity and health-related quality-of-life(HRQoL).Survival with a poor quality-of-life may not be acceptable depending on individual patient values and preferences.Hence,as mortality decreases within critical care,it becomes increasingly important to measure intensive care unit(ICU)survivor HRQoL.HRQoL measurements with a preference-based scoring algorithm can be converted into health utilities on a scale anchored at 0(representing death)and 1(representing full health).They can be combined with survival to calculate quality-adjusted life-years(QALY),which are one of the most widely used methods of combining morbidity and mortality into a composite outcome.Although QALYs have been use for health-technology assessment decision-making,an emerging and novel role would be to inform clinical decision-making for patients,families and healthcare providers about what expected HRQoL may be during and after ICU care.Critical care randomized control trials(RCTs)have not routinely measured or reported HRQoL(until more recently),likely due to incapacity of some patients to participate in patient-reported outcome measures.Further differences in HRQoL measurement tools can lead to non-comparable values.To this end,we propose the validation of a gold-standard HRQoL tool in critical care,specifically the EQ-5D-5L.Both combined health-utility and mortality(disaggregated)and QALYs(aggregated)can be reported,with disaggregation allowing for determination of which components are the main drivers of the QALY outcome.Increased use of HRQoL,health-utility,and QALYs in critical care RCTs has the potential to:(1)Increase the likelihood of finding important effects if they exist;(2)improve research efficiency;and(3)help inform optimal management of critically ill patients allowing for decision-making about their HRQoL,in additional to traditional health-technology assessments. | Vincent Issac Lau Jeffrey A Johnson Sean M Bagshaw Oleksa G Rewa John Basmaji Kimberley A Lewis M Elizabeth Wilcox Kali Barrett Francois Lamontagne Francois Lauzier Niall D Ferguson Simon J W Oczkowski Kirsten M Fiest Daniel J Niven Henry T Stelfox Waleed Alhazzani Margaret Herridge Robert Fowler Deborah J Cook Bram Rochwerg Feng Xie | 2022 | World Journal of Critical Care Medicine2022，11，4： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员